Development Level

Tbio 3 | 10,625
Tchem 1 | 1,890

IMPC Term

abnormal bone structure 1 | 131
decreased bone mineral content 1 | 157
decreased effector memory CD8-... 1 | 24
decreased lean body mass 1 | 195
decreased total body fat amoun... 1 | 186
increased CD8-positive, naive ... 1 | 3
increased bone mineral content 1 | 92
increased lean body mass 1 | 107
increased total body fat amoun... 1 | 57

Disease

glioblastoma 3 | 5,572
subependymal giant cell astrocytoma 3 | 2,287
Duchenne muscular dystrophy 2 | 602
adult high grade glioma 2 | 2,148
atypical teratoid / rhabdoid tumor 2 | 4,369
cutaneous lupus erythematosus 2 | 1,056
interstitial cystitis 2 | 2,299
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
invasive ductal carcinoma 2 | 2,950
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
ovarian cancer 2 | 8,484
pancreatic cancer 2 | 2,300
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
posterior fossa group A ependymoma 2 | 1,511
primary pancreatic ductal adenocarcinoma 2 | 1,271
psoriasis 2 | 6,685
sonic hedgehog group medulloblastoma 2 | 1,482
Acrocallosal syndrome 1 | 12
Antiphospholipid syndrome 1 | 18
Astigmatism 1 | 27
Atopic dermatitis 1 | 944
Breast cancer 1 | 3,094
COPD 1 | 113
Cancer 1 | 2,346
Carcinoma 1 | 2,147
Choledocholithiasis 1 | 13
Cycloplegia 1 | 13
Dermatitis, Allergic Contact 1 | 66
Disease Progression 1 | 125
Endometriosis 1 | 535
HAIM-MUNK SYNDROME 1 | 1
Hearing Loss, Partial 1 | 25
Keratosis 1 | 34
Myocardial Ischemia 1 | 169
Myopia 1 | 99
Obesity 1 | 616
Palmoplantar keratosis 1 | 36
Papillon-Lefevre disease 1 | 4
Paratyphoid fever 1 | 10
Periodontal Diseases 1 | 1
Periodontal disease 1 | 37
Periodontitis, Juvenile 1 | 1
Plague 1 | 19
Pleural empyema 1 | 10
Presbyopia 1 | 19
Prostatic Neoplasms 1 | 471
Stomach Neoplasms 1 | 282
Substance-Related Disorders 1 | 114
Waldenstrons macroglobulinemia 1 | 765
active ulcerative colitis 1 | 477
aldosterone-producing adenoma 1 | 664
astrocytoma 1 | 1,493
atypical teratoid/rhabdoid tumor 1 | 1,095
breast carcinoma 1 | 1,614
cystic fibrosis 1 | 1,665
dermatomyositis 1 | 933
diabetes mellitus 1 | 1,663
ductal carcinoma in situ 1 | 1,745
fibroadenoma 1 | 557
gastric carcinoma 1 | 832
hearing impairment 1 | 40
interstitial lung disease 1 | 291
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
juvenile dermatomyositis 1 | 1,189
limb girdle muscular dystrophy 2B 1 | 74
lung adenocarcinoma 1 | 2,713
lung cancer 1 | 4,466
lung carcinoma 1 | 2,844
nasopharyngeal carcinoma 1 | 1,056
non diabetic and post-ischemic heart failure 1 | 200
non-small cell lung cancer 1 | 2,798
osteosarcoma 1 | 7,933
pancreatic carcinoma 1 | 567
posterior fossa group B ependymoma 1 | 1,530
primary Sjogren syndrome 1 | 789
sarcoidosis 1 | 358
spina bifida 1 | 1,064
tuberculosis and treatment for 3 months 1 | 327
type II diabetes mellitus and post-ischemic heart failure 1 | 89
ulcerative colitis 1 | 2,087

Tissue

Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444
Blood and immune system 3 | 17,995
Male tissues 3 | 17,969

Target Family

Non-IDG 2 | 11,971
Enzyme 1 | 4,146
GPCR 1 | 406

Grant Application

5R01DK069605-09 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
InaD-like protein PATJ Tbio Non-IDG -1.88739 77.1 91
Dipeptidyl peptidase 1 CTSC Tchem Enzyme -3.22597 1740.5 143
Proteinase-activated receptor 3 F2RL2 Tbio GPCR -0.20838 2.70 157
Partitioning defective 6 homolog alpha PARD6A Tbio Non-IDG -0.94338 9.52 184